MedPath

Evaluation of the Accuracy of a Novel Sleep Monitoring Technology Compared to Polysomnography in the Intensive Care Unit

Not Applicable
Conditions
Sleep
Neurological - Other neurological disorders
Registration Number
ACTRN12623001193662
Lead Sponsor
Royal Melbourne Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

•Aged 18 years and over
•Expected ICU length of stay > 24 hours
•Richmond Agitation Scale Score (RASS) between -2 to 0
- RASS score should be stable within these limits for the 2 hours preceding enrolment.
- Any divergence outside these parameters occurring between enrolment and application of the study devices should be discussed with the principal investigator to determine suitability to proceed.

Exclusion Criteria

•Suspected or confirmed diagnosis of acute central nervous system pathology
•Acute head and neck injury or surgery
•Acute psychiatric or behavioural disturbance
•Acute toxic ingestion
•History of seizures
•Continuous infusions of propofol or benzodiazepines
•Position restrictions that may limit the application of monitoring devices
•The treating Intensivist’s perception that devices will be poorly tolerated by the patient for the study period
•Previous enrolment in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in total sleep time, measured using sleep scientist interpreted polysomnography and automated algorithm scored Somfit data.[Total sleep time between the manually scored polysomnography data and the algorithmically scored Somfit data The 12 hours following commencement of Somfit and polysomnography data collection]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath